Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Support Care Cancer. 2019 Jun 3;28(2):845–855. doi: 10.1007/s00520-019-04834-w

Table 4.

Significant odds ratios (95% confidence intervals) from logistic regression analyses comparing symptom burden groups on sociodemographic and medical variables

T1 Groups T2 Groups
FSC vs.
Average
FSC vs. MS Average vs.
MS
A vs. EFAS A vs. SFPS SFPS vs.
PFAS
EFAS vs. MS PFAS vs. MS SFPS vs. MS PFAS vs. A
Sociodemographic
 Age --- 0.95
(0.90, 1.00)
0.94
(0.90, 0.98)
--- --- --- --- --- --- ---
 Married vs. not married 0.33
(0.13, 0.80)
--- --- 4.55
(1.13, 18.35)
6.24
(1.36, 28.66)
--- --- --- --- ---
Medical
 Stage at dx: II (vs. III) --- --- 2.92
(1.13, 7.58)
--- --- --- --- --- --- ---
 Surgical intervenion
  Lumpect vs. “Other” --- --- 3.24
(1.01, 10.42)
--- --- --- --- --- --- ---
  Mastect vs. “Other” --- --- 3.43
(1.07, 11.01)
--- --- --- --- --- --- ---
 BMI --- --- --- --- --- 1.17
(1.02, 1.33)
--- --- --- ---
 Current medications
  Analgesics --- 4.22
(1.26, 14.16)
--- --- --- --- --- --- --- ---
  Antidep --- --- --- --- --- --- 4.38
(1.19, 16.13)
--- --- ---
  Minor tranq --- --- --- 0.17
(0.04, 0.68)
--- --- 8.95
(2.38, 33.62)
--- --- ---
 Comorbidities
  Asthma --- 6.14
(1.14, 33.07)
--- --- --- --- 18.91
(1.92, 185.95)
11.14
(1.08, 115.54)
19.50
(1.80, 211.21)
  Arthritis --- --- --- --- --- --- --- 3.58
(1.00, 12.81)
--- 5.09
(1.08, 24.02)
  “Other” disease --- 4.90
(1.15, 20.96)
--- --- 0.09
(0.01, 0.98)
--- --- --- --- 12.50
(1.32, 118.48)

Note. Only pairwise comparisons that were statistically significantly different are presented in this table (all ps ≤ .05). FSC = Fatigued with sleep complaints; MS – Minimal symptoms; SFPS = Severely fatigued with poor sleep; EFAS = Emotionally fatigued with average sleep; PFAS = Physically fatigued with average sleep; A = Average; Lumpect = Lumpectomy; Mastect = Mastectomy; Antidep = Antidepressants; Minor tranq = minor tranquilizers. For surgical intervention “other’ indicates double mastectomy or neoadjuvant chemotherapy. For comorbidities “other’ indicates any disease not specifically queried.